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WHO WILL LEAD SCIENCE? 
"Science is driven by creative individuals. 
Given room and scope, scientists develop new 
ways of_thinking, new methods and 
new approaches· to attacking problems. " 
Nobel laureate Torsten Wiesel, M.D. 
President Emeritus, Ro�kefeller University 
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WHAT FACTORS PROMOTE KNOWLEDGE? 
Excerpts from a discussion 
about the value of creativity 
and risk taking in science. 
A conversation among 
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The discussion begins with actor Alan 
Alda engaging the Rockefeller scientists 
in a conversation about the value of basic 
science, and the role of creativity and risk 
taking in research discoveries. 
Torsten Wiesel (TW): Most of the 
money spent since the 1970s as a 
result of President Nixon's "war on 
cancer " went into basic molecular 
biology and genetics, which laid the 
groundwork for the developments 
we are going to see in the next few 
decades. 
Alan Alda (AA): Although the 
goal was to cure cancer, research 
money went into pure science, 
which is undirected and goes wher­
ever it's led? 
TW: It's not that it went undirect­
ed. The way science works, you can't 
direct it too much because scientists 
must be free. But the goal of trying to 
understand the basic mechanisms -
cell differentiation, cell growth and 
how cells become cancerous - is 
very basic. And that was addressed in 
the years after the "war on cancer." 
AA: What factors promote new 
knowledge? 
TW: The best of science has 
always been creative, a reason why art 
and science belong together. They are 
not 9-to-5 jobs, in which you have 
certain things you do and then you 
go home and think about something 
else.You always think about what you 
are doing in science. Work is part of 
you when yo1; are a scientist, as it is 
for you, Alan, as an actor. 
Science is driven by creative individuals 
who are given room and scope to develop 
new ways of thinking, new methods, new 
ways of approaching problems, and to take 
risks to create new kn<?wledge. 
Tom Sakmar (TS):And let's not forget that 
knowledge is the goal of science, and that 
information isn't always translated directly 
into knowledge. Sequencing the human 
genome was a great advance, but putting that 
sequence information to practical use 
requires a much more detailed understanding 
of basic mechanisms than we now have. 
Gunter Blobel (GB): For example, it's 
shocking how little we know about how a 
cell works, even a primitive bacterial cell.And 
that will take a long, long time to figure out. 
TS: So you can assemble groups of people 
like the Human Genome Project did and 
have large collaborative projects to accumulate 
information, but innovation and creativity 
come from the initiative of individual 
scientists. 
Paul Greengard (PG):The research of90 
percent of scientists recognized by a Nobel 
Prize went against the current thinking. If it 
hadn't, it wouldn't have been novel, and it 
wouldn't have made a major contribution. 
AA: How do you know you're not wast­
ing your time? 
PG: Most scientists who contributed cre­
ative ideas didn't have any doubts and were 
happy that so many other scientists didn't 
think they were right, because this gave them 
time to develop and test their ideas.While you 
feel bad when researchers say nasty things 
about you after you give a speech, it doesn't 
affect your conviction that you're right. 
GB: In my own research, it was nice to 
realize that others thought I was wrong 
(laughter) because it left me time to work it 
out myself. 
AA: When did you know you were right? 
TW: It's very intuitive, actually. 
GB:You have to do a few experiments to 
test your idea.You also have to have the ability 
to let your idea die if there is the slightest evi­
dence that it is not supported by experiments. 
AA: How do you make sense of the 
human genome data? 
GB:We need the help of physicists and 
mathematicians to mine the vast amount of 
sequence data of the human genome. For 
example, Rockefeller University physicist Eric 
Siggia looks for sequence elements that might 
be involved in the regulation of transcription. 
AA: Which research field is becoming 
exciting? 
TW: Stem cell research is certainly one 
area in which a lot of progress should occur 
in the next decade. 
GB:We will have to understand how to 
make from these stem cells the heart cells or 
cartilage cells or whatever other cells we want 
to replace in patients. It may take an entire 
generation of scientists before we can do this. 
AA: Will scientists answer these questions 
with new tools and new ways of calculating? 
PG:The tools today are enormously more 
powerful than they were 10 years ago. 
Rockefeller has made tremendous contribu­
tions in methodologies - in electron 
microscopy, for example. This drives the 
research. There's an old German saying: "Die 
Methode ist alles," or "methods, tools are 
everything." Incredible 1discoveries are going 
to be made just by this knocking out and 
removing one gene after another and finding 
out what they do. 
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TW: Industry is moving 
very powerfully, interacting 
with academic research. For 
example, genome sequencing 
became an industrial project, 
and now proteomics is, with 
the sequencing and description 
of proteins. Industry is going to 
dominate there. 
AA: Gunter, why are you 
shaking your head at that? 
GB: Proteins are not as sim­
ple as DNA. Proteins are very 
complicated in their interac­
tions and how they are organ­
izing each other in the cell. 
Companies will be able to do 
some proteomics, but will 
never do the more exciting 
things like what Rod 
MacKinnon, a scientist at 
Rockefeller, has achieved in 
solving the atomic structures of 
two very important ion chan­
nels (see page 8). 
AA: When he won the 
Nobel Prize, Gunter talked 
about proteins that carry signals 
that act like ZIP Codes in a 
cell. That sounded to me like a 
laudable, deliberate effort to 
make clear the research. 
DISCUSSION PANEL 
Alan Alda 
Best known for his role in the 
popularTV series "M'YJ.*S*H ," 
he portrayed Nobel laureate and 
physicist Richard Feynman in 
the play "QED." A regular 
reader ef scientific journals, he 
interviews researchers for the TV 
program "Scientific American 
Frontiers. " 
Gunter Blobel, M.D., Ph.D. 
Head of Laboratory of Cell 
Biology 
John D. Rockefeller Jr. Professor; 
Investigator, Howard Hughes 
Medical Institute (HHMI) 
Nobel Prize in Physiology 
or Medicine, 1999 
Paul Greengard, Ph.D. 
Head of Laboratory of 
Molecular and Cellular 
Neuroscience 
Vincent Astor Prefessor 
Nobel Prize in Physiology 
or Medicine, 2000 
Thomas P. Sakmar, M.D. 
Acting President 
Head of Laboratory of 
Molecular Biology and 
Biochemistry 
Richard M. and Isabel P. 
Furlaud Prefessor; Associate 
Investigator, HHMI 
Torsten Wiesel, M.D. 
President Emeritus 
Vincent and Brooke Astor 
Prefessor Emeritus 
Nobel Prize in Physiology 
or Medicine, 1981 
GB: I don't think there is any concept 
that you can't make understandable to the 
educated lay public. I always tell my students 
and postdocs - if you can't explain to your 
grandmother what you are doing, probably 
you don't understand it yourself properly. 
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TS:The issue of educating young students 
is extremely important. They have to have a 
level of understanding of how things have 
progressed and how things were 20 years ago 
compared to now, and some perspective that 
knowledge is not static. In public lectures, I 
"Science is the art of 
the soluble, as Peter 
Medawar told us. You 
make hypotheses that 
are testable and that 
can be disproven. 
It is difficult to pre­
dict what will happen 
in the next 20 or 30 
years. There could be 
revolutionary develop­
ments that will cat­
alyze quantum leaps 
and provide informa­
tion that we could not 
even dream ef now." 
Gunter Blobel 
put_ my own personal history 
in context - what I was 
taught in high school, and 
what I'm learning now. 
How so many fields that I 
now use routinely in my 
own work didn't exist 25 
years ago. Science is progres­
sive; knowledge is passed 
from generation to genera­
tion. 
AA: Is the future of sci­
ence going to be brighter if 
there is this excommunica­
tion between conservative 
and traditional-thinking sci­
entists and people who are 
probing into the dark 
unknown? 
PG: No, because science 
selects for certain personalities - people 
who want to find truth. If the researcher 
with the crazy idea seems very smart, the 
typical approach is "let him or her have a 
shot at it." 
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AA: And yet there are these revolutions in 
the way we view reality. That's true in acting 
as well. When Brando came in, actors who 
had thought that they were realistic suddenly 
realized that they were very stagey. Brando 
helped introduce a new version of reality. 
GB:This happened at Rockefeller with 
Oswald Avery, who discovered in 1944 that 
DNA carried genetic material. But many 
scientists opposed this. Avery died before his 
research was recognized as one of the most 
monumental discoveries of the last century. 
PG: If another scientist comes along with 
a new way of thinking, and says that your 
way is all wrong, and "this is the way it 
works," it's very upsetting intellectually. So 
there is a tendency, an emotional response, to 
resist those new ideas. It's not an admirable 
response, but that's the reality of being 
human. 
AA: An outsider expects science not to 
squabble about protecting territory or intu­
itions. 
TW: Scientists are people. Time is your 
best friend, because if you do good work, 
even if it's opposed by other scientists, with 
time it's going to be recognized. 
AA:What if the territory changes? How 
does a research institute deal with a "hot" 
new area that demands rethinking an old 
question or an entire field? 
GB: Rockefeller doesn't have departments. If 
a scientist who heads a lab retires, we don't have 
to continue the lab like most universities con­
tinue a department. We can create new laborato­
ries to rapidly address the next questions 
because we don't have to deal with the burden 
and boundaries of departments. That's unique to 
Rockefeller. 
AA: A very creative way to organize. 
Did the Nobel Prize that you each received 
help your field of science in any way? 
PG: It helps the people in the field feel good 
because the entire field is recognized. 
AA: With all that you know about the brain, 
do you sense that computing will ever approach 
what the human brain can do? 
PG: Oh, much more. The interesting ques­
tion to me is whether computers will do cre­
ative things in the way we do .. 
AA: What's the thing about wanting to get 
there first? 
TW: It's a matter of seeing for the first time 
something that nobody knew before and you 
didn't either. That's a powerful imprinting thing, 
and with a few conditioning events you are 
hooked for good to search for new discoveries. 
AA: I'm very grateful to have been asked to 
come talk with you folks, because it's been a 
delightful afternoon for me. 
THE ROCKEFELLER UNIVERSITY 
"Scientific knowledge advances 
when scientists have concentrated 
time to focus on their research .  
It took me three years of investi-
gation to report any results. 
That wouldn't be possible in 
most universities." 
Bruce Merrifield, Ph.D. 
John D. Rockefeller Jr. Professor Emeritus 
Nobel Prize in Physiology or Medicine, 1984 
The art of the soluble 
Rockefeller University empowers its 
stellar faculty with the time, freedom 
and resources to follow the science 
wherever it takes them. Where is it 
taking them? 
The following pages spotlight 
pathbreaking research of a few of the 
university's 75 major laboratories. 
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RODERICK MACKINNON 
John D. Rockefeller Jr. Professor, HHMI investigator 
Seeing proteins' beauty 
and function in their f orn1 
"Imagine you want to wiggle your finger," 
says Roderick MacKinnon, M.D., slowly 
moving a finger of his right hand to illustrate 
his explanation about the importance of ion 
channels in body cells. 
"Electrical signals, little impulses, go all 
the way from your brain down the long 
extended nerve fibers to induce the contrac­
tion of the muscles in your finger. 
"The same sorts of electrical signals allow 
me to move and breathe, my heart to beat and 
for all of us to have all the thoughts that we 
have," he continues. "Those impulses come 
from ions moving across the cell membrane." 
Because so many life-sustaining functions 
begin with ions crossing membranes of cells, 
MacKinnon conducts his research there too. 
He has solved the structure of the potassium 
ion channel and a chloride ion channel. 
Without detailed images of these channels, 
researchers cannot begin to understand how 
even the transmission of nerve impulses 
actually works, and how it malfunctions, 
contributing to health disorders and drug 
side effects. 
When MacKinnon decided to "solve " the 
structure of the potassium ion channel, some 
scientists cautioned him to reconsider. After 
all, many others had spent years and had failed 
to visualize this specialized protein, a gate­
keeper as well as a gateway for potassium ions. 
Ignoring the skeptics, MacKinnon perse­
vered - and succeeded in solving the struc­
ture of the potassium ion channel in 1998, 
only two years after joining T he Rockefeller 
University. 
When MacKinnon and his colleagues 
reported this research in Science, its editors 
illustrated the cover of that issue with a 
three-dimensional, high-resolution image of 
the potassium channel. Science later declared 
the study one of the year's "breakthroughs." 
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Subsequent research revealed the channel's 
inner characteristics, homing in on viewing 
the atomic-scale parts of the channel and 
understanding better how the structure forms 
mechanistic features: il). effect, learning how 
function and form are intertwined in the 
channel's design. 
In 2002, in a remarkable follow-up to 
their.potassium ion channel research, and this 
time featured on the cover of Nature, 
MacKinnon and his colleagues published the 
structure of yet another channel - a chlo­
ride channel. A distinctive hourglass shape, 
seen for the first time in MacKinnon and 
colleagues' research, defines the chloride 
channel, and provides a striking contrast to 
the pyramid-shaped cavity of the potassium 
ion channel. 
To visualize the structures of these ion 
channels, MacKinnon's lab uses X-ray crys­
tallography, a multi-step process resulting in a 
diffraction pattern from a crystal, which is 
then rendered as a three-dimensional pic­
ture. The result offers literally an atom-for­
atom image of the ion channels in question 
- a view of a beautiful evolutionary solu­
tion to the problem of moving things across
solid membranes.
That nature could come up with some­
thing so ingenious is one of the breathtaking 
marvels of basic research, and exemplifies 
why MacKinnon and many of his colleagues 
and students at Rockefeller undertake their 
work- for the sheer joy of discovery. 
When then President Torsten Wiesel, 
M.D., asked him to join the university's fac­
ulty, MacKinnon says, "Rockefeller told me,
in essence, that they like scientists who take
risks and they were willing to take me on in
that attempt. It is rare that an institution can
offer that kind of support."
A protein has a sophisticated architectural plan cre­
ated by nature. Solving protein structures - visu­
alizing their shapes - is an ongoing, and impor­
tant, activity of basic science researchers. 
In addition to their canny beauty, protein struc­
tures provide us with an understanding of the 
process of life. Each proteins shape corresponds 
with its function, whether it is to "shake hands" 
with other proteins, or to serve as a passage for 
small molecules in the body movingfrom one place 
to another. Pictured here, the structure of a chloride 
ion channel, a specialized protein, shows that it 
permits two streams of chloride ions (shown in red) 
to flow through its center, moving tens of thou-
- sands of ions per second from one side of a cell wall
to the other.
For an interactive illustration of an ion channel, 
visit www.rockefeller.edu/ discovery. 
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MARIA KARAYIORGOU 
Genetic clues to schizophrenia 
I. 
Maria Karayiorgou, M.D. , heads one of the 
few laboratories in the world that searches 
for the genetic causes of schizophrenia by 
looking at people with the disease before 
studying lab animals. 
"It's the other w�y around in most labs," 
says Karayiorgou, head of The Rockefeller 
University's Laboratory of Human 
Neurogenetics. "All of our hypotheses and 
studies begin with human patients." 
Her unique approach has led to the iden­
tification of several genetic mutations that 
may underlie schizophrenia - as well as to 
possible clues about how to better diagnose 
and treat this disease. 
Affiicting two million Americans, schizo­
phrenia is characterized by disordered think­
ing and deficits in emotional and social 
behavior. Like heart disease and diabetes, it is 
The chart above is one of the research tools that 
help Maria Karayi01gou study the inheritance of 
genes that confer susceptibility to schizophrenia. 
Charts - also called pedigrees - show family 
members' relationships to each other. This pedigree 
links together 2 7 schizophrenic patients from the 
Micronesian island of Kosrae. 
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triggered by multiple genes whose activity 
patterns in specific body cells change, often 
in reaction to one or more unknown envi­
ronmental influences. 
Before Karayiorgou joined Rockefeller in 
1996, her search for the identity of these genes 
led her to a small region of human chromo­
some 22.This particular patch ofDNA, she 
discovered, was lacking, or "microdeleted," in 
peopie with schizophrenia: of the 100 unrelat­
ed people with the disease whom she studied, 
all possessed these microdeletions, while all 
200 healthy" control" subjects did not. 
At Rockefeller, she and other researchers 
created the first animal model of schizophre­
nia by deleting or "knocking out" a gene 
, called PRODH. It codes for an enzyme that 
regulates levels of the amino acid praline, a 
crucial brain chemical required for proper 
functioning of neurons. Mice lacking this 
gene possess a hallmark of human schizo­
phrenia: inability to filter the multitude of 
sensory inputs, such as sounds, to focus on 
only one stimulus at a time. 
Karayiorgou continues to explore chro­
mosome 22. Recently she and collaborators 
published a systematic study using DNA 
from three independent populations: chil­
dren with childhood-onset schizophrenia, 
and adult North Americans and South 
African Afrikaners with schizophrenia. Of 
the 13 genes studied, two conferred suscepti­
bility to schizophrenia - one of which 
turned out to be PRODH.
"This was an interes_ting finding because 
the particular pathway in which PRO DH is 
involved is largely undescribed," says 
Karayiorgou. "It is a novel pathway that will 
open up several different avenues for new drug 
development." 
_\\'c the_refore have shown tha1 genealo�ca! research, the ·, !J?pulaoon, allhoug_h tedious and laoor-iniensive, is f�blearuJ� aidourgcneoc rud1es. 
CO\'.CLL' IONS 
Taken together, results from our thret studies sugg� tbal, Ille 
Afrikaner population conforms lo the standards d
es1� io a 
. ulation appropriate for geoome-11ide 
scan_s that 
''.plo11 LD to 
�:p common, multigenic disorde�, 
such as sch1zophrenl3. 
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Through this pedigree, Maria 
Karayiorgou s research team 
traced to one person - or
founder - seven of the 5 6
South African Afrikaner
families whom the scientists
are studying as part of their
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Skin and hair: 
Means to a genetic end 
Skin and hair proteins fascinate Elaine Fuchs, 
Ph.D., who heads the university's Laboratory 
of Mammalian Cell Biology and Development. 
From proteins that act like glue to hold 
together skin to those that form a tough 
outer barrier to keep harmful pathogens out 
and essential fluids in the body, Fuchs's 
research goal is the same: understand how 
skin proteins function at the level of the cell. 
While unraveling the secrets of our body's 
largest organ, she finds clues to the genetic 
origins of skin diseases, including cancer. 
Fuchs is addressing one of today's crucial 
biological questions: "What are the amazing 
properties of stem cells of the body that enable 
them to develop into tissues and organs?" 
Her lab studies how skin stem cells are 
able to divide and churn out skin cells in a 
Petri dish, a process used to treat burn vic­
tims. "If we understand enough about the 
biology of skin stem cells, and how they can 
make both hair and skin, will we be able in 
the future to coax stem cells of the skin or 
hair into becoming something that they nor­
mally would not become, such as a blood 
vessel to the heart, neurons for the brain, or 
pancreatic islet cells?" she asks. 
These tissues can be severely damaged by, 
respectively, heart attack,Alzheimer's and 
diabetes. If skin stem cells can be persuaded 
to become other tissues, they could be the 
basis for new treatments. 
Scientists must first thoroughly under­
stand normal stem cells. "There is much 
promise for stem cells in revolutionizing 
medicine, but there is so much we must first 
learn about stem cells before we can reach 
the stage of even knowing whether this 
might be possible," she points out. 
Unlike other stem cells, skin stem cells 
can be cultured easily in the lab. With these 
lab cultures, Fuchs and her research team 
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study stem cells and learn about how they 
choose between making skin epidermis or 
making hair. Employing modern molecular 
biology techniques, the scientists trick stem 
cells into making one choice - for example, 
to become hair. The se1entists test their find­
ings by introducing small mutations in spe­
cific skin genes in laboratory mice. More 
often ,than not, this key step has guided them
to the genetic bases of human skin disorders. 
Fuchs's lab has determined the genetic 
basis of a type of skin tumor that affects the 
scalp. The lab hopes to understand the genet­
ics of squamous and basal cell carcinomas, 
the most common types of human cancers in 
the world. "Because of their extraordinary 
self-regenerating properties, stem cells, when 
gone awry, are the likely cause of many if not 
most types of human cancers," says Fuchs. 
While her goal is to unravel the biology 
of normal cells, not the causes of skin dis­
eases, Fuchs's results exemplify the unexpect­
ed benefits ofbasic research to medicine as 
well as science. 
Skin cells' durability comes from the protein 
keratin. This protein also makes up the bulk 
of hair cells. To switch on hair keratin genes 
and turn cells into keratin factories, hair pre­
cursor cells need a signal to tell them to make 
a transcription factor between beta-catenin 
and a partner protein. The hair follicle at right 
is stained with antibodies to reveal the pres­
ence of beta-catenin �ime green). In blue are 
the cells' nuclei. Beta-catenin normally stays 
at the cells' borders, but the hair precursor cells 
(at base) have received their signal and begun 
to move with their partners to the nucleus. 
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JAN BRESLOW 
Frederick Henry Leonhardt Prefessor 
JEFFREY FRIEDMAN 
Marilyn M. Simpson Professor, HHMI investigator 
MARKUS STOFFEL 
Robert and Harriet Heilbrunn Prefessor 
"Syndron1e X" genetics on island ofKosrae 
The cluster of disorders known as "Syndrome 
X" is relatively unfamiliar to the public. It is 
not a new disease, but a new name for a col­
lection of health problems - obesity, dia­
betes, high blood pressure and high blood 
cholesterol. Tens of millions of people have 
one or more of these four disorders. 
Because all four conditions simultaneous­
ly can affect the same individual or many 
family members, a common set of flawed 
genes may trigger the syndrome. To look 
for a possible common thread in all four, 
and to find the genetic roots of each disease, 
Rockefeller University laboratories that 
specialize in research on obesity, diabetes, 
hypertension and heart disease are jointly 
conducting research on Syndrome X. 
Their partner is the Department of 
Health on the Pacific island of Kosrae in 
Micronesia, about 5 ,400 miles from Los 
Angeles. 
The Rockefeller scientists have turned to 
this remote population of over 3,000 people 
for two reasons. One, most Kosraeans can trace 
their heritage to a relatively small "founder" 
population of about 50 people who came 
from Polynesia about 1,000 years ago. Later, in 
the mid- to late-19th century, Caucasian 
whalers visited and in many cases settled on 
the island, and so today many Kosraeans can 
trace their ancestry to both groups. 
The second reason the Kosraeans are ideal 
for studies of Syndrome X involves the more 
recent "westernization" of their lifestyles. 
For most of their thousand-year history, 
Kosraeans were active. They ate native foods 
and were reported to be relatively lean. But 
in the years following World War II, most 
14 
began leading a sedentary lifestyle while eat­
ing foods with high salt and fat contents. 
Subsequently, a disproportionate percentage 
of people on the island have developed one 
or more conditions associated with 
Syndrome X. 
By analyzing the genetic inheritance pat­
terns of the entire Kosraean population, 
Rockefeller scientists Jan Breslow, M.D., 
Jeffr�y Friedman, M.D., Ph.D. , and Markus 
Stoffel, M. D., Ph.D., hope to solve the ongo­
ing mystery of why some people develop 
these diseases, while others with the same 
lifestyle do not. 
They have conducted a comprehensive 
epidemiological and genetics study involving 
over 90 percent of the adult population -
or 2,188 men and women - on Kosrae. For 
each Syndrome X disorder, Friedman and his 
Rockefeller colleagues are scrutinizing DNA 
samples provided by volunteers in Kosrae to 
identify genes involved in each disease and to 
verify previous findings of candidate genes 
from their research with lab animal models 
or human patients in the United States. 
Blood samples were provided willingly, 
because Kosraeans want to understand why 
they are so vulnerable to the Syndrome X 
disorders. "People on the island should bene­
fit from this study because they have become 
more aware of these health problems," 
explains Friedman, director of the Starr 
Center for Human Genetics at Rockefeller. 
"This awareness is a starting point for pre­
vention as well as treatment." 












Theater of the cell. 
Genes were biology's command performers 
during the last_ decade of the 20th century. 
We expected their monologues· to tell us 
much about life. Today, genes are but one 
class of actors in the theater of the 
cell. Other _leading parts go to 
proteins and complexes that 
become active when 
genes, or groups of genes, 
tell them ·to do so. 
Terry Gaasterland, 
Ph.D., has the singular 
qualifications to help us 
understand these actors' 
"motivations," revealing their 
mechanisms of communication 
and transit within the cell. 
Gaasterland's tools for studying genes and 
other molecular actors are computers, not 
pipettes or Petri dishes. 
"I examine data generated by gene 
sequencing labs all over the world," says the 
head of Rockefeller's Laboratory of 
Computational Genomics. "I knit the data 
together with gene expression: data and other 
sources to form a picture of the biological 
systems inherent in all organisms. Whole 
genomes, or the maps of all genes for organ­
isms like human, fly and mouse, have given 
us much more information to work with." 
New ways ef visualizing information come with 
the new territory ef computational genomics. 
Gaasterland devised the above "ball ef yarn'' 
system that depicts genes' interactions with one 
another when they are expressed, or turned on. 
Here, several genes in the bacteria Vibrio 
cholera interact when substances necessary for 
the organism 5 metabolism are present . All the 
points along the circle5 circumference represent 
genes.Arrows indicate genes.consistently co­
expressed - in this case, during metabolism. 
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This information helps scientists identify 
. families and homologues of proteins and 
their structures. 
Proteins, molecules scripted and regulated 
. by genes, are the essei:ce of cellular life. 
They're the workhorses that send and receive 
signals, bind with receptors and meet up 
with other proteins to play important roles 
in t�e hody. Complexes - groups of pro­
teins or proteins mixed with other cellular 
products - perform jobs only when they 
are activated, or turned on. 
Why is this important? Major diseases 
from cancer to cystic fibrosi� are based on 
mistakes in the structure or composition of 
oneor more proteins. Ultimately, knowing 
more about which genes turn on and off for 
which disease, and how the corresponding 
proteins (individually or in key groups) mal­
function, allows scientists to see the entire 
"cast" performing in a disease. This knowl­
edge provides the means for designing new 
drugs to intervene with the proteins and 
recast disease-causing players. 
As part of their research, Gaasterland and 
her colleagues build software tools to infer 
relationships and to model protein systems. 
These intricate role-playing exercises help 
scientists understand how .disease evolves in 
the body. 
Because scientific interactions at 
· Rockefeller are not restricted by traditional
departme�tal structures, Gaasterland's compu­
tational �nsights are quickly transferred to the 
university's many biology labs. The fluid 
boundaries between disciplines help to clarify 
existing biological research and prompt new 
measurements to be taken in the laboratory. 
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A protein� structure often 
reveals something about its 
role in the body, depending 
on the counterparts with 
which it peiforms. Terry 
Gaasterland compares the 
"readout" ef an organism� 
gene expression data (back-
. ground) with protein struc­
tures (foreground) to learn 
more about proteins'func­
tions. Her comparisons often 
suggest new experimentsfor 




Irene Diamond Assistant Prefessor 
Tailor-n1aking a cancer vaccine 
for people "With n1ultiple n1yelon1a 
People with multiple myeloma rarely get 
well even after undergoing chemotherapy 
and transplants of stem cells from their 
own bone marrow. However, a cure to this 
pernicious blood cancer is being nurtured 
in the "translational" research of Rockefeller 
University physician-scientist Madhav 
D hodapkar, M.D. 
Like several of the university's scientists, 
Dhodapkar traverses the worlds of patient 
care and basic research, translating the accom­
plishments of each to improve public health. 
Dhodapkar's scientific journey begins and 
ends with the patient with multiple myeloma, 
which develops when immune system cells 
go awry. 
From his patients with this disease, 
Dhodapkar retrieves immune cells, including 
one called the dendritic cell. The cells are iso­
lated and processed to develop a tumor vac­
cine specifically tailor-made for each patient. 
Dendritic cells - discovered by Ralph 
Steinman, M.D. , who is the Henry G. Kunkel 
Professor at Rockefeller and head of the 
university's Laboratory of Cellular Physiology 
and Immunology - normally call into 
action the "killerT cells" of the body's 
immune system. To guide killer T cells to 
their precise targets - which typically are 
bacteria or viruses that have invaded the 
body, or cancerous tissue in the body -
the dendritic cells engulf some of the target. 
Dendritic cells then display on their surfaces 
various proteins or other substances from 
cancers or foreign bodies. 
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However, because they often escape the 
attention of the dendritic cells, cancers are 
not always attacked as they should be by the 
powerful killerT cells. 
To insure that the dendritic cells recognize 
the cancer, Dhodapkar's lab primes a sample 
of these cells from a patient with multiple 
myeloma. The cells are "treated" with a sub­
stan�e known to activate killerT cells. During
carefully monitored clinical research at The 
Rockefeller University Hospital, patients 
with multiple myeloma are then injected 
with the primed dendritic cells. 
If over time it proves safe as well as eff ec­
tive in persuading the killer T cells to recog­
nize and destroy multiple myeloma in a large 
group of patients, this new experimental 
treatment may become a "cancer vaccine." 
Cluster containing 
dendritic cell and other 
immune system cells. 
Multiple myeloma cells 
in the blood (above) can't 
be removed by surgery 
the way most tumors in 
the body can, and they're 
resistant to conventional 
chemotherapy and radia­
tion . In a novel treat-
ment, Madhav 
Dhodapkar amplifies 
patients' own immune 
cells, including the den­
dritic cell (opposite), in 
the lab. He then returns 
them to the body with a 
bonus - an experimental
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cancer drug. Enhancing 
the immune cells, and 
using them as a delivery 
system, forms the basis ef 
a potential new treatment 
for this and other incur­
able cancers. 
19 
MARY E. HATTEN 
Frederick P. Rose Prefessor 
NATHANIEL HEINTZ 
HHMI investigator 
Building a genetic atlas of the brain 
Two Rockefeller scientists are shooting 
time's arrow forward at the rate of about a 
decade a month as they "map" the 1,0, 000 
genes active in the human brain in record 
time. 
If not for their novel research method, the 
remainder of this century would be needed 
to pinpoint when and where in the brain 
gene expression, or activation, occurs. The 
"bacterial-transgenic" method used by 
Nathaniel Heintz, Ph.D. , and Mary E. 
Hatten, Ph.D. , accelerates this goal with 
rapid-fire precision. 
"We can analyze up to 500 genes per 
year, and we've already done so on about 
200," says Heintz. "We'll cover all the well­
known genes in the first couple of years." 
Why create a map of the genes that are 
active in the brain? "The actual pattern of 
gene expression can give you a first inference 
into the function of a gene," Heintz explains. 
When a gene is active, it expresses a signal 
- a messenger molecule to specific cells in
the brain. The messenger instructs the cells
to manufacture a specific protein. Depending
on its genetic recipe, that protein can help
form another brain cell or one of the many
chemical substances, or neurotransmitters,
through which brain cells communicate
with each other.
When neurological diseases such as 
Alzheimer's occur, one or more proteins are 
misshapen, too abundant or insufficient. 
Finding and scrutinizing the genes responsi­
ble for these protein mistakes provide clues 
to the origins - and possible treatment -
of the disease. 
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When their National Institutes ofHealth­
supported project is complete, Hatten and 
Heintz will deliver to the worldwide scien­
tific community a free, unrestricted, compre­
hensive database on ge?e expression in the 
brain. 
For Hatten and Heintz, both neuroscien­
tists, their genetic atlas recreates for all scien­
tists tp.e experience of sitting down at a 
microscope and seeing thousands of cells and 
their corresponding structures. The atlas will 
benefit neuroscientists in every conceivable 
basic and clinical research field, because it 
will give unprecedented levels of insight on 
neurological development and stroke, 
Alzheimer's and Parkinson's disease. 
"We know this atlas will be important," 
says Hatten."Our initial work already has 
provided us with intriguing new informa­
tion about cell migration, the specialized 
movement of cells in the brain, that we never 
would have found using existing tech­
niques." 
Hatten and Heintz have named their 
ambitious project "GENSAT," for Gene 
Expression Nervous System Atlas. This 
acronym is meant to invoke LANDSAT, a 
satellite system for investigating vast terrain 
in close detail. 
The difference is that Hatten and Heintz's 
research "topography" is the brain. 
In the top right scientific 
image, the expression of a 
gene called "dopamine 
receptor Drdla" is high­
lighted in cells in the brain 
region called the striatum. 
Cells with these corre­
sponding receptor proteins, 
which were manufactured as 
a result of the genes activa­
tion, project fibers (see arrows 
in large image, above left) to 
another area of the brain, 
called the substantia nigra 
(detail, lower right). 
.,, , .... . "'�-­
' ) � .� .· ·� . 
Since dopamine, a chemi­
cal messenger, is deficient in 
the brains of people with 
Parkinson s disease, under­
standing the genetics of the 
dopamine-producing system 
of the brain improves under­
standing about the origins of 
this neurological disorder. 
Mapping the expression, or 
activity pattern of a single 
gene, such as Drdla, over 
time reveals the cells associ­
ated with that gene and the 
other cells in the brain with 
which they interact. 
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TOM MUIR 
Creating "n1olecular Legos®" by 
snapping together natural and synthetic n1olecules 
Tom Muir, Ph.D. , brings a different set of 
tools to the study of biology- those of 
organic chemistry. 
While organic chemists manipulate mol­
ecules to create a test tube full of a desired 
compound, Muir goes one step further: his 
creations are designed to study precise bio­
logical problems in the test tube and the cell. 
"Not only can we use these sophisticated 
approaches to manipulate the structure and 
function of genes and proteins in the test 
tube, but we can increasingly do this in liv­
ing cells or whole animals," says Muir, who 
heads the Selma and Lawrence Ruben 
Laboratory of Synthetic Protein Chemistry. 
Called "chemical biology," this emerging 
field allows Muir and other scientists to rap­
idly ascertain functional information about 
key biological molecules, including those 
involved in cancer, Alzheimer's disease and 
other disorders, and to create systematically 
novel drugs for the possible treatment of 
these diseases. 
One of the new relatively easy-to-use 
tools that has emerged from Muir's lab stacks 
together chunks of proteins in a technique 
called "expressed protein ligation." 
This novel approach - available to all 
scientists, not just those at The Rockefeller 
University - provides for the first time a 
technique to synthesize a full-sized protein, 
an important tool in understanding any 
protein's overall function in a cell. 
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Recently Muir's lab has applied similar 
protein-linking technology to study protein 
folding. Newly made proteins - which 
typically adopt a linear topology, or form, 
with dangling ends lik� those of a string -
cannot function properly until they fold 
into the correct three-dimensional shape. 
Indeed, misfolded proteins are associated 
with Alzheimer's, cystic fibrosis and "mad 
cow" disease. 
But some proteins adopt a circular 
topology, leading Muir to ask what effect 
such an altered form might have on protein 
folding. Like a true chemist, Muir tackled 
the problem by artificially linking the two 
free ends of a protein together into a circle, 
then observed it fold. He found that the 
new molecule folded into the same shape as 
its natural linear form, but more intriguing, 
it did so more quickly. 
"This suggests that topology plays a very 
important role in protein folding, which is 
an emerging theme in the protein folding 
field," says Muir. 
Muir's overriding goal, however, is to 
develop chemical tools that any researcher 
can use. "After all," he asks, "what good are 
the tools if only a few people can use them?" 
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Translating research into hun1an health 
"I like donating my cells to science," explains Susan, a clinical study volunteer 
at The Maurice R. and Corinne P Greenberg Hospital of The Rockefeller 
University. 
The first in the nation dedicated to clinical research, the 92::-year-old hospital 
serves as a bridge connecting the university's basic research labs to the world of 
human health, to people with diseases. People like Susan. 
Susan is afflicted with a common autoimmune disorder. Rockefeller 
physician-scientists' studies of the disease in Susan inspire the direction of 
many laboratory investigations, and help translate hard-won lab discoveries 
into potential health care and biomedical research achievements. 
The hospital, where paintings by Frank Stella and other renowned artists 
hang in the hallways and patient rooms, bustles on most days with the activity 
of physician-scientists, nurses and other health care professionals, and M.D.­
Ph.D. students in the top-rated joint program Rockefeller offers with Weill 
Medical College of Cornell University and Memorial Sloan-Kettering 
Cancer Center. 
On any day, the most important people there are the study participants, all of 
whom are involved in approved clinical research protocols. 
"The patients' altruism is vital to medical progress," says Barry Coller, M.D., 
David Rockefeller Professor and the hospital's physician-in-chief. "We owe 
them a great debt and must make their safety our highest pr ior ity. Everyone at 
Rockefeller views this commitment as a sacred trust." 
Susan concurs: "I would not volunteer if Rockefeller was not such a 
supportive environment. The hospital cares for the total person - clinically, 
mentally and emotionally." 
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When overweight lab mice or 
humans lose weight due to 
dieting, their bodies' metabo­
lism changes. Diet-induced 
weight loss results in a decline 
in blood levels of leptin, the 
protein byproduct of the 
"obese" (or "ob") gene dis­
covered by Jeffrey Friedman, 
M.D., Ph.D., at The
Rockefeller University.
What other metabolic 
changes occur in diet-induced 
weight loss? Will leptin treat­
ments keep the hormone at 
normal levels in the dieters' 
bodies and help accelerate 
weight loss, or lessen some of 
the unwanted effects of a low­
calorie diet? 
Since low leptin levels may 
be a potent stimulus to weight 
gain, Friedman and Sagit 
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Zolotov, M. D. (right), are 
evaluating the effects of leptin 
treatment on overweight 
women on a low-calorie, 
healthy diet. This project, one 
of the "translational research" 
programs at The Rockefeller 
University Hospital (above), 
is the most comprehensive 
study ever conducted on the 
metabolic changes that occur 
in dieting. 
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Hepatitis C research: 
Whatever it takes 
The body's immune system holds the key to 
eliminating hepatitis C, the source of a hidden 
epidemic in the U.S. Locating that key depends 
on scientists' learning why many people's 
immune systems fail to mount an effective 
response to hepatitis C, while others' rise to the 
viral challenge. 
Charles Rice, Ph.D., director of the 
Center for the Study of Hepatitis C at the 
university, aims to do "whatever it takes " to 
combat this illness because of its devastating 
toll on the people of New York City and 
around the world. 
Only a quarter of the four million people 
in the United States infected with hepatitis C 
know they have the virus. The life-threaten­
ing liver disease that occurs with infection 
takes decades to develop, and for those in the 
final stage of disease, liver transplant remains 
the only treatment. If more people with the 
virus were tested and sought treatment, scien­
tists could better understand the immune sys­
tem's interaction with the virus. Creating a 
metropolitan center for clinical and basic 
research advances the research - and aids 
more patients. 
In the three years that Rice has headed the 
new center, the basic research has blossomed. 
"Immunologists are having a heyday now," 
says Rice. "We know that the immune 
response in individuals chronically infected 
with hepatitis C has a strong antibody com­
ponent, but a very weak cellular component." 
Figuring out how to boost the cellular com­
ponent could be an important part of future 
therapy or vaccination. 
The center's basic research focuses inten­
sively on the immune system's white blood 
cells (T and B cells) that attack and destroy 
invading microbes. 
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"More people than we thought clear the 
virus from their system, and we need to 
understand how they do this," adds Rice. 
"Having the center's home base in NewYork 
City serves the research well: we have a large 
pool of people receivfng clinical care for 
hepatitis C, as well as a clinically challenging 
sub-group also infected with HIV But we'd 
like ,to treat, and study, more people."
A new clinical research component of the 
center supports pediatric sufferers of hepatitis 
C. "We need to know more about when and
how to treat children," says Margaret R.
MacD onald, M.D., Ph.D., co-founder of the
Center for the Assessment and Treatment of
Children Infected with Hepatitis C.
W hile hepatitis C immunology is yielding 
clues about the disease, other areas demand 
intense research attention. "We really need to 
get the virus's replication cycle going in cell 
culture," says Rice. "With this next phase of 
the research worked out, we'll be able to 
examine many aspects of the virus that we 
can't understand right now and open new 
avenues for drug development." 
Rice's record demonstrates that he gets 
results. In 1997, before joining Rockefeller, 
he led the team that made the first infectious 
clone for the virus, demonstrating that the hep­
atitis C virus alone - not one of its brother or 
sister hepatitis viruses - is sufficient to cause 
the disease. In 1999, he and his colleagues dis­
covered mutations in the virus that allow it to 
replicate its genome in cell culture - another 
milestone in research on the disease. 
Charles Rice (right), Maurice R. and 
Corinne P Greenberg Professor and director 
of the Center for the Study of Hepatitis C, 
and postdoctoral fellow A rash Grakoui study 
the entire life cycle of the hepatitis C virus. 
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RESEARCHERS IN TRAINING 
Learning science 
by doing science 
"At Rockefeller, nobody boxes you in as a scientist," says fourth-year graduate 
student Tshaka Cunningham, describing the university's uniquely unstructured, 
highly successful training of students to become leaders and innovators in bio­
medical science. 
Cunningham, recipient of the university's prestigious David Rockefeller 
Fellowship in 2002, is learning by "doing sciente " in one of the world's top 
AIDS research labs: the Aaron Diamond AIDS Research Center, directed by 
David Ho, M.D., Irene Diamond Professor at The Rockefeller University. 
Students at Rockefeller quickly get into the nuts and bolts of conducting 
scientific research because coursework is minimal, unlike most other graduate 
training programs in the life sciences. At Rockefeller, graduate training often is 
described as an "apprenticeship with a master scientist." 
From the master scientist, or mentor, as well as the other researchers in the 
lab, the student learns a framework for asking the crucial scientific question, 
designing an experiment to answer the question and interpreting the results. 
Cunningham, an apprentice with Mark Muesing, Ph.D., is training for a 
scientific career in HIV/ AIDS research. With his colleagues, Cunningham has 
identified a possible platform for gene-therapy-based vaccines 
"As a Rockefeller graduate student, my mind moves quickly and my hands 
keep pace in the lab," says the Princeton University graduate. "What's my incen­
tive? In my area of research on HIV/ AIDS, 40 million people will potentially 
benefit if we make a major breakthrough." 
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INTERDISCIPLINARY RESEARCHERS IN TRAINING 
The laws of living n1atter 
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For mathematicians or physicists seeking 
potential biomedical applications of their 
highly specialized training, 21st-century 
"biology provides almost an embarrassment 
of riches," says Erik van Nimwegen, Ph.D., 
a postdoct�ral fellow at the Center for 
Studies in Physics and Biology. 
Biology is "like another civilization; the 
whole way of thinking is very different from 
physics," adds Tsvi Tlusty, Ph.D., another fel­
low at the center, presciently established in 
1994 atThe Rockefeller University. 
These and other young physicists and 
mathematicians study the civilization of 
biology as part of the university's plan to 
build more bridges, and more opportunities 
for collaboration, between the disciplines. 
While biologists eagerly clear space at 
their lab benches - and computers - for 
mathematicians and computer scientists to 
help organize and analyze the complex data 
of the DNA code and the proteins that 
genes determine, physicists open new 
avenues for understanding "living matter." 
Studying how a cell behaves, for example, 
reveals as much as knowing what it con­
tains. Biology depends more and more on 
physicists to explain symmetry and change, 
or stability and instability within living 
organisms down to single molecules. 
Silk and soap settle a 
century-old flap, and 
encourage physicists to 
study turbulence in living 
organisms. 
Here the movements 
of a silk filament in liq­
uid soap, research by 
Rockefeller scientist 
Albert Libchaber in col­
laboration with several 
colleagues, reveal the 
dynamics of how .flexible 
objects move in fluid 
forces. The group of scien­
tists discovered that, tech­
nically, a flag could fly 
straight rather than con­
stantly flap, given the 
right conditions. This also 
applies to understanding 
how fish swim in water. 
One of the center's scientific leaders, 
Albert Libchaber, Ph.D., the university's 
Detlev W Bronk Professor, trained in 
condensed matter physics and pioneered 
the field of complexity theory. Libchaber 
views biology as a model frontier that 
will help establish new physics and 
mathematics. 
Where some may see physics and 
mathematical contributions as a form of 
applied science, Libchaber and his 
colleagues take an inverse view. Biology 
offers a universe as vast as the Milky Way, 
revealing laws undiscovered in other 
natural systems. 
Several years ago, Libchaber began a 
project to learn more about fluid dynam­
ics. To create a simple version of a "fish 
swimming" phenomenon, Libchaber, 
along with his Rockefeller students and 
postdocs and his colleagues at New York 
University's Courant Institute of 
Mathematical Sciences, studied silk 
filaments in soap film, revealing the four 
main conditions of an object moving in 
water or air. 
The resulting publication in Nature
revealed for the first time how flags flap 
in the wind. The findings served as a 
starting point for a more elaborate project 
studying tigerfish as they move through 
water. Information about the turbulence 
effects of the aquatic animals' movements 
may become the cornerstone of new 
developments in physics. 
Using a similar approach, Libchaber 
and his lab members study DNA, but not 
for its biological functions. They study the 
physics of DNA - how it is structured, 
broken down and reassembled during 
replication - to theorize new means of 
computing. DNA provides a more 
complex set of information-processing 
methods than any computer, ever con­
ceived by humans. 
As well as new theories, new tools 
emerge from the interface between 
physics and biology. For several years, 
Benoit Dubertret, Ph.D., a postdoctoral 
fellow who works with Libchaber, has 
been searching for b!ological applica­
tions of quantum dots - crystals of only 
a few hundred atoms that are visible with 
a single wavelength of light. 
With another Rockefeller scientist, Ali 
H. Brivanlou, Ph.D., head of the
Laboratory of Molecular Vertebrate
Embryology, Dubertret has succeeded in
applying quantum dots to illuminate how 
embryonic frogs develop into a whole 
orgarusm.
Could quantum dots also illuminate a 
healthy human cell's change to malignan­
cy? Only a physicist working with a biol­
ogist may ever answer the question. 
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Using molecular beacons, Noel 
Goddard (above left) studies 
rigidity of single-strand DNA. 
As a graduate student in the 
Laboratory of Experimental 
- Condensed Matter Physics, she
combines her formal training in
physics with an apprenticeship
in molecular biology mentored
by laboratory head Albert
Libchaber (above).
The university's graduate 
program is "very effective," says 
Nobel laureate and former 
Rockefeller President Torsten 
Wiesel, M. D. "A student 
spends time in a lab and learns 
from and interacts with a master 
scientist." 
Rockefeller University has 
many educational partners, 
including Weill Medical College 
of Cornell University and 
Memorial Sloan-Kettering 
Cancer Center. With them, it 
offers a highly rated M. D. -
Ph.D. program to train physi­
cian-scientists for the future. 
Through New York University's 
Courant Institute of 
Mathematical Sciences, 
Rockefeller of ers students curric­
ula linking the disciplines of 
biology, physics, mathematics and 
computation, providing young 
scientists with tools to under­
stand the patterns of life. 
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Selected prizes and awards 
2001-2002 
BRIAN T. CHAIT 
Frank H. Field and Joe 




Academy Fellow, New York 
Academy of Sciences 
JOEL E. COHEN 
Mayor's Award for Excellence 
in Science and Technology 
BARRY S. COLLER 
Warren Albert Foundation 
Award 
JAMES E. DARNELL JR. 
Albert Lasker Award for 
Special Achievement in 
Medical Science 
Academy Medal for 
Distinguished Contributions 
in Biomedical Science 
(New York Academy of 
Sciences) 
TITIA DE LANGE 





Damon Runyon-Eli Lilly 
Clinical Investigator Award 
JEFFREY M. FRIEDMAN 
Bristol-Myers Squibb 
Award for Distinguished 
Achievement in Metabolic 
Research 
HIRONORI FUNABIKI 
Searle Scholar Award 
CHARLES GILBERT 
Fellow, American Academy 
of Arts and Sciences 
PAUL GREEN GARD 
NARSAD Julius Axelrod 
Neuroscience Award 
(shared with Eric Kandel and 
Arvid Emil Carlsson)' 
A. JAMES HUDSPETH
Fellow, American Academy
of Arts and Sciences
JOSHUA LEDERBERG 
Benjamin Franklin Medal for 
Distinguished Achievement 




Arnold and Mabel 
Beckman Award 





BRUCE S. MCEWEN 
Edward J. Sachar Award 
(Department of Psychiatry, 
Columbia University College 
of Physicians and Surgeons) 
JOHN MCKINNEY 
Ellison Medical Foundation 
New Scholar Award in 
Global Infectious Disease 
Leslie B. Vosshall, Ph.D. (right), and Mike 
Rout, Ph.D., are the most recent of five 
Rockefeller scientists to have been honored 
with the PECASE (Presidential Early 
Career Award for Scientists and Engineers) 
since the award was established in 1996. 
FERNANDO NOTTEBOHM 
Ellison Senior Scholar 




ROBERT G. ROEDER 
Dickson Prize in Medicine 
(University of Pittsburgh) 
MICHAEL P. ROUT 
Presidential Early Career 
Award for Scientists and 
Engineers 
SHAI SHAHAM 




Fund Investigator Award 
in Pathogenesis of 
Infectious Disease 
RALPH M. STEINMAN 




Unrestricted Grant Award 
for Metabolic Diseases 
LESLIE B. VOSSHALL 
Presidential Early Career 
Award for Scientists and 
Engineers 
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In laboratory cultures of 
human and rodent brain tis­
sue
) 






his Rockefeller University 
colleagues showed that the 
hormone estrogen prevents 
the accumulation of "senile 
plaques JJ that build up in 
the brains of most people 
with the devastating disease 
Alzheimer's. 
Above is a neuron
) 
the 
most common type of brain 
cell in humans and most 
animals. This image of a rat 
neuron was stained to iden­
tify the locations of proteins 
forming the "senile 
plaques. JJ 
The plaquejorming pro­
teins are located primarily in 
a part of the neuron called 
the Golgi compartment 
(bright area of image) - a 




and shipping certain cellular 
products. Greengard found 
that estrogen scoots the 
plaquejorming proteins out 
of the Golgi compartment . 
Scientists hypothesize that 
the longer these proteins stay 
in the Golgi network
) 
the 
more likely they may be to 
develop into the beta amy­
loid of "senile plaques. n 
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Fron1 DNA to a postgenon1ic world:_ 
Discoveries that ( continue to) transf orn1 science 
W ith the 50th anniversary of the discovery of 
DNA's double-helix structure by James Watson and 
Francis Crick at Cambridge University upon us, 
the world of science eagerly anticipates a season of 
celebratory conferences and honors marking the 
occasion. Rockefeller University will join the fes­
tivities, to honor its own chapter in the textbook of 
DNA history. 
In 1944, Rockefeller scientists Oswald Avery, 
Colin MacLeod and Maclyn McCarty showed for 
the first time that DNA is the chemical substance 
of heredity. This crucial finding set the stage for 
Watson and Crick's unveiling the physical structure 
of this double-stranded molecule nine years later. 
Half a century later, DNA has become a cultural 
phenomenon in its own right, with ripple effects 
that reach far beyond the research lab and into 
every area of human endeavor - business, philoso­
phy, ethics, the arts. For scientists working in our 
own so-called postgenomic era, the span of less 
than 60 years siI_,1ce The Rockefeller University's 
discovery is uncanny. 
Visit any of The Rockefeller University's 75 
major laboratories today and you will find scientists 
writing new chapters in the textbook of DNA 
history. Among them: Robert G. Roeder, Ph.D., the 
Arnold and Mabel Beckman Professor and head of 
the Laboratory of Biochemistry and Molecular 
Biology, who stands at the center of research to reveal 
the basic principles of mammalian transcription. 
Transcription is the process by which the 
identical sets of genetic instructions contained in 
each of the body's 200 distinct types of cells are 
Charles Lindbergh 
and Alexis Carrel 
Oswald Avery. Colin Macleod. 
Florence Sabin, renowned 
anatomist and histologist 
becomes first female 
member of Institute, 
•�==========$-1 appear on 'lime" 
and Maclyn McCarty 
discover DNA carries 
hereditary information. 
1944 
June 14. 1901 




collaborate with New 
York City Board of 
Health to reduce bacte­







Peyton Rous discovers virus 
can cause cancer. 1911 
1915 1920 1925 
Donald van Slyke 
perfects appara­







Founder's Hall completed. 1906 
magazine cover 
with their perfusion 
apparatus. which 
keeps organs alive 
in the lab for two 
���::::
-·� weeks. 1938 
1930 1935 1940 
Karl Landsteiner receives 1930 
Nobel Prize for classifying blood 
groups; he later discovers 
Rh blood factor 
Wendell Stanley 
shows a virus can 
be crystallized. 
1935; he shares 
1946 Nobel Prize 
with John Northrop 
WWII: Rebecca C. Lancefield's 
expertise in identifying bacterial 




microscopy reveals inner 
structure of cells. 1945: 
for founding the field of cell 
biology.Albert Claude. 
Christian de Duve. and 
George E. Palade share 
1974 Nobel Prize 
1950 1955 
Stanford Moore and 
William Stein describe 
the enzyme pancreatic 
ribonuclease. which 
breaks down RNA. 
1959: for this work 
they receive 1972 
Nobel Prize 
"Because Rockefeller 
offers its faculty 
extraordinary resources and freedom
)
individualized to distinguish, for example, a skin 
cell from a muscle cell. Through transcription, the 
cell's machinery issues marching orders of precisely 
which genes to express, or "switch on." A gene 
must be "on" to generate recipes for proteins; the 
particular proteins expressed ultimately determine 
the cell's function in the body. 
they are able to take scientific risks that 
would be unimaginable anywhere else. n
And, because diseases such as cancer, 
Alzheimer's and AIDS can arise when transcrip­
tion breaks down, understanding how a gene 
transcribes its insttuctions accelerates research to 
create more effective medical therapies. 
In 1944, The Rockefeller University ushered 
biology into the modern age. Today, Roeder is 
one of the university's 75 scientific leaders making 
the discoveries that continue to transform science. 
Method for 
, synthesizing 




he wins 1984 
Nobel Prize 
Dendritic cell. vital white 
blood cell that alerts immune 
system to presence of foreign 
invaders in diseases. 
discovered by Zanvil Cohn 
and Ralph Steinman, 1973 
Mike Young clones 
"per" gene. which 
affects circadian 
rhythms. in fruitflies. 
1984 Robert Roeder identi­
fies and clones first 
gene-specific tran­
scriptional regulatory 
factor - key to how 
genetic information in 
DNA is converted into 
protein. 1988 
Joshua Lederberg, Ph.D. 
President Emeritus 
Raymond and Beverly Sackler Scholar 
Nobel Prize in Physiology or Medicine, 1958 
Roderick MacKinnon 
reveals structure of 
potassium ion channel. 
shedding light on nerve 
cell communication, 1998 
Giinter Blobel award­
ed 1999 Nobel Prize 
for discovering pro­
teins are distributed 
throughout cells by 
a "ZIP Code" system 
James E. Darnell Jr. 
awarded 2002 
Lasker Award for 
Special Achievement 
in Medical Science 
1960 1965 1970 1975 1980 1985 1990 1995 2000 2001 
Gerald Edelman awarded 1972 
Nobel Prize for showing 
chemical structure of antibodies 
Rockefeller awards Ph.D.s 
to first graduating class. 
1959 
Vincent Dole develops methadone for 
managment of heroin addiction. 1960s; 
receives 1988 Lasker Award 
Emil Gotschlich 
receives 1978 
Lasker Award for his 
role in developing 
vaccine against 
Group C meningitis 
Mary Beth Hatten and 
Nathaniel Heintz identify 
1 gene involved in direct­
ing nerve cells to their 
destinations as brain 
grows.1994 
litia de Lange helps determine 
chromosome ends, called 
telomeres, are looped, a dis­
covery relevant 
to cancer and 
aging, 1999 
Led by David Ho, scientists at The 
Rockefeller University Hospital and Aaron 
Diamond AIDS Research Center begin tri­
als of" drug cocktail" that reduces death 
rates from AIDS in U.S., 1995 
THE ROCKEFELLER UNIVERSITY 
Paul Greengard awarded 
2000 Nobel Prize for 
discovering how dopamine 
and other chemical 
messengers affect brain 
Vincent Fischetti 
develops new anthrax 
treatment consisting 
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